These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8471769)
1. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Bash RO; Crist WM; Shuster JJ; Link MP; Amylon M; Pullen J; Carroll AJ; Buchanan GR; Smith RG; Baer R Blood; 1993 Apr; 81(8):2110-7. PubMed ID: 8471769 [TBL] [Abstract][Full Text] [Related]
2. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997 [TBL] [Abstract][Full Text] [Related]
3. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene. Iolascon A; Faienza MF; Coppola B; Moretti A; Basso G; Amaru R; Viganò G; Biondi A Leukemia; 1997 Mar; 11(3):359-63. PubMed ID: 9067574 [TBL] [Abstract][Full Text] [Related]
5. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR. Curry JD; Smith MT Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356 [TBL] [Abstract][Full Text] [Related]
6. The translocation (1;14)(p34;q11) in human T-cell leukemia: chromosome breakage 25 kilobase pairs downstream of the TAL1 protooncogene. Xia Y; Brown L; Tsan JT; Yang CY; Siciliano MJ; Crist WM; Carroll AJ; Baer R Genes Chromosomes Cancer; 1992 Apr; 4(3):211-6. PubMed ID: 1382561 [TBL] [Abstract][Full Text] [Related]
7. Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia. François S; Delabesse E; Baranger L; Dautel M; Foussard C; Boasson M; Blanchet O; Bernard O; Macintyre EA; Ifrah N Genes Chromosomes Cancer; 1998 Sep; 23(1):36-43. PubMed ID: 9713995 [TBL] [Abstract][Full Text] [Related]
8. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. Baer R Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619 [TBL] [Abstract][Full Text] [Related]
9. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805 [TBL] [Abstract][Full Text] [Related]
10. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Cheng JT; Hsu HL; Hwang LY; Baer R Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease. Szczepański T; Langerak AW; Wolvers-Tettero IL; Ossenkoppele GJ; Verhoef G; Stul M; Petersen EJ; de Bruijn MA; van't Veer MB; van Dongen JJ Leukemia; 1998 Jul; 12(7):1081-8. PubMed ID: 9665194 [TBL] [Abstract][Full Text] [Related]
13. TAL1 expression does not occur in the majority of T-ALL blasts. Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214 [TBL] [Abstract][Full Text] [Related]
15. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045 [TBL] [Abstract][Full Text] [Related]
16. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice. Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836 [TBL] [Abstract][Full Text] [Related]
17. SIL/TAL1 recombination in adult T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma. Kwong YL; Chan D; Liang R Cancer Genet Cytogenet; 1995 Dec; 85(2):159-60. PubMed ID: 8548743 [No Abstract] [Full Text] [Related]
18. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. Ono Y; Fukuhara N; Yoshie O J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. van Grotel M; Meijerink JP; van Wering ER; Langerak AW; Beverloo HB; Buijs-Gladdines JG; Burger NB; Passier M; van Lieshout EM; Kamps WA; Veerman AJ; van Noesel MM; Pieters R Leukemia; 2008 Jan; 22(1):124-31. PubMed ID: 17928886 [TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia. Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]